JPM26: Integra resets by fixing supply and riding reimbursement tailwinds

Integra’s “two horizon” plan aims to secure its foundations of finances and supply while speeding growth through R&D ...
Seeking Alpha

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq: IART), a leading global medical technology company, commends the Centers for Medicare & ...
Nasdaq

Here's Why Investors Should Retain Integra (IART) Stock Now

Integra LifeSciences Holdings Corporation IART is likely to grow in the coming quarters, given the healthy demand for its industry-leading products within Codman Specialty Surgical (“CSS”). The ...
Benzinga.com

Why Is Integra LifeSciences Stock Soaring On Monday?

On Monday, Integra LifeSciences Holdings Corporation (NASDAQ:IART) reported third-quarter adjusted EPS of $0.41, down from $0.76 a year ago, beating the consensus of $0.39. The company reported sales ...
Seeking Alpha

Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq: IART), a leading global medical technology company, is pleased to announce the FDA 510(k) ...
Business Insider

Integra Lifesciences: A Strong Buy on Strategic Acquisition and Promising Growth Trajectory

Integra Lifesciences (IART – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst David Turkaly from JMP Securities remains neutral on the stock and ...